Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.

Rajfer J, Aliotta PJ, Steidle CP, Fitch WP 3rd, Zhao Y, Yu A.

Int J Impot Res. 2007 Jan-Feb;19(1):95-103. Epub 2006 Jul 27.

PMID:
16871272
2.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

3.

Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.

Eur Urol. 2006 Aug;50(2):351-9. Epub 2006 Mar 20.

PMID:
16766116
4.

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.

Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.

Eur Urol. 2004 Sep;46(3):362-9; discussion 369.

PMID:
15306109
5.

Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.

Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, Ishii N, Kamidono S.

Urology. 2006 Oct;68(4):845-51.

PMID:
17070365
6.

Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.

Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, Lim E, Shen W, Venugopalan M, Chan M.

Int J Urol. 2006 Jun;13(6):721-7.

7.

Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.

Saylan M, Khalaf I, Kadioglu A, Shoair KZ, Beheiry A, Wang WC, Kopernicky V, Esen A.

Int J Clin Pract. 2006 Jul;60(7):812-9.

8.

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.

Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L.

J Urol. 2004 Sep;172(3):1036-41. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15311032
9.

Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.

Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V.

Asian J Androl. 2006 Nov;8(6):685-92. Epub 2006 Jul 11. Erratum in: Asian J Androl. 2007 Jan;9(1):39.

10.

Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.

Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.

Arch Neurol. 2007 Nov;64(11):1584-92. Epub 2007 Sep 10.

PMID:
17846260
11.

The efficacy and safety of tadalafil: an update.

Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ, Shen W, Cordell WH.

BJU Int. 2004 Jun;93(9):1276-81.

12.

Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.

Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM Jr, Hague JA, Ahuja S.

J Androl. 2005 May-Jun;26(3):310-8.

13.

The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.

Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S.

J Urol. 2004 Aug;172(2):652-7. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15247754
14.

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.

Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.

J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22.

PMID:
18722631
15.

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.

Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R.

Urology. 2003 Jul;62(1):121-5; discussion 125-6.

PMID:
12837435
16.

Tadalafil for treatment of erectile dysfunction in men on antidepressants.

Segraves RT, Lee J, Stevenson R, Walker DJ, Wang WC, Dickson RA.

J Clin Psychopharmacol. 2007 Feb;27(1):62-6.

PMID:
17224715
18.

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS.

J Urol. 2007 Apr;177(4):1401-7.

PMID:
17382741
19.

A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men.

McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P.

Int J Clin Pract. 2005 Feb;59(2):143-9.

PMID:
15854188
20.

Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.

Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C; Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group..

Urology. 2005 Feb;65(2):353-9.

PMID:
15708052

Supplemental Content

Support Center